Skip to main content
Equibles

Brevan Howard Capital Management LP

Position in EBS — Emergent BioSolutions Inc.

CIK 1512857 ST. HELIER, Y9
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$326,116
+$55,429 QoQ
Shares Held
38,916
+19.3% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#82
of 194 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Brevan Howard Capital Management LP holds $20,713,489 across 26 Drug Manufacturers - Specialty & Generic names. EBS ranks #15 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 231,624 $3,678,189
2 UTHR
UNITED THERAPEUTICS Corp
 4,174 $2,261,598
3 ZTS
Zoetis Inc.
 26,423 $1,898,755
4 LQDA
Liquidia Corp
 20,664 $1,647,540
5 LNTH
Lantheus Holdings, Inc.
 14,589 $1,618,503
6 AMRX
Amneal Pharmaceuticals, Inc.
 85,545 $1,480,783
7 HIMS
Hims & Hers Health, Inc.
 38,148 $1,322,591
8 BCRX
Biocryst Pharmaceuticals Inc
 96,574 $965,740

All Filings in EBS

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $326,116 38,916
2026-03-31 $270,687 32,613
2025-12-31 $124,675 10,087
2025-09-30 $122,598 13,900
2025-06-30 $119,459 18,724
2025-03-31 $63,087 12,981
2024-06-30 $198,175 29,058
2023-09-30 $46,855 13,781